GL1X · GenesisL1 explorer

Research workbench

Displacement of WDR5 from chromatin by a pharmacological win site inhibitor with picomolar affinity

Analyse Displacement of WDR5 from chromatin by a pharmacological win site inhibitor… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6E23
Type
protein
Length
602 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Wd repeat-containing protein 5
UniProt
P61964
Ligands
HLJ
Pockets
3 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 0% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AWd repeat-containing protein 5protein2990% helix, 52% strandP61964
BWd repeat-containing protein 5protein3030% helix, 53% strandP61964

Ligands and binding sites

  • HLJ · N-[(3,4-dichlorophenyl)methyl]-3-(6-fluoro-2-methylpyridin-3-yl)-5-{[(2E)-2-imino-3-methyl-2,3-dihydro-1H-imidazol-1-yl]methyl}benzamide · ligand · 2 copies · chains A, B
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110810.800.8197HLJ
27770.780.8174HLJ
3550.400.8112empty

Interfaces

1 interface between chains.

  • A–B · 271 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 6E23 · Displacement of WDR5 from chromatin by a pharmacological WIN site inhibitor with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.